Review Papers Claim by Claim

Visual-first analysis — prevalence of risk factors in casualty sample (n=210)

Key figure: postural instability — central vs peripheral drivers

Evidence synthesis (visual second): what the review claims and supporting data

• 1) Falls and dementia: prevalence and magnitude. Shaw & Kenny report ~75% of older people with cognitive impairment/dementia will fall each year and that dementia roughly doubles fall risk compared with cognitively intact elders; this is drawn from prospective observational studies summarized in the review. Shaw & Kenny on prevalence
• 2) Postural instability — central processing deficit. The review argues that gait/balance abnormalities in Alzheimer's disease and vascular dementia (shorter step length, slower gait, greater sway and stride variability) stem predominantly from impaired central integration (sensory organization and attention/executive resources). This mechanistic claim is supported by later objective COP-velocity and dual-task gait studies that show graded worsening across cognitive impairment (example supporting data: COP AAMV and dual-task gait velocity reductions). Shaw & Kenny on central processing JAD 2014 postural sway
• 3) Medication and psychotropics. The review synthesizes meta-analyses showing psychotropic drugs roughly double fall-risk and notes high prescription rates of such drugs in cognitively impaired patients (e.g., 63% in one sample vs ~4% in earlier community samples), making medication a major modifiable contributor. Strength of evidence is consistent across settings but causality is limited by observational designs and confounding by indication. Medication risks in Shaw & Kenny Anticholinergic risks (2014)
• 4) Neurocardiovascular instability (orthostatic hypotension, carotid sinus hypersensitivity). Shaw & Kenny compile evidence for autonomic dysfunction in AD and higher prevalence of orthostatic hypotension and carotid sinus hypersensitivity (including very high prevalence in DLB), which plausibly increases fall and fracture risk. Evidence includes observational cardiovascular/autonomic testing and histopathology supporting brainstem/autonomic nuclei degeneration. Meta-analyses since then confirm orthostatic hypotension associates with adverse outcomes (mortality; association with falls/ stroke less consistent). Autonomic dysfunction in Shaw & Kenny Orthostatic hypotension meta-analysis
• 5) Visual impairment and environment. The review notes associations between poor vision (acuity, depth perception, contrast sensitivity) and falls, and documents many environmental hazards in homes of dementia patients — yet population studies often find no simple positive association between number of hazards and falls; interaction with cognitive impairment (reduced hazard awareness) likely matters. Vision and environment in Shaw & Kenny

Critical appraisal — strengths, weaknesses and blindspots

1. Strengths: coherent synthesis of mechanistic (autonomic, central integration) and epidemiologic data; clinically actionable framing (modifiable medication, orthostatic hypotension, environmental checks); inclusion of casualty-sample prevalence that highlights multifactorial clustering in fallers with dementia. Shaw & Kenny strengths
2. Limitations and biases:
   • Heavy reliance on observational and clinic/casualty samples limits generalizability to community-dwelling dementia cohorts and inflates prevalence estimates (selection bias).
   • Heterogeneous measures and diagnostic criteria across cited studies (dementia subtypes, fall definitions, orthostatic test methods) increase risk of misclassification and reduce reproducibility.
   • Limited randomized/dementia-specific prevention trials — the review extrapolates from general older-adult RCTs, which may not transfer to dementia populations where central mechanisms and compliance differ.
   • Recall/reporting bias is especially problematic in cognitively impaired subjects; Shaw & Kenny acknowledge under-reporting of falls and unreliable histories in dementia, which complicates etiological inference.
   Shaw & Kenny limitations

Practical conclusion (evidence-weighted)

The review's main, well-supported claim — that falls in cognitively impaired older adults are multifactorial with larger contributions from central postural-control deficits, medication and autonomic/cardiovascular dysfunction than in cognitively intact elders — remains consistent with subsequent quantitative work (postural sway, dual-task gait, autonomic studies). However, a high-quality causal chain (prospective, adequately powered RCTs in dementia-targeted populations testing multifactorial vs tailored interventions) remains scarce; the review correctly flags this evidence gap. JAD 2014 supports central deficit

What would change the conclusions?

• Large, prospective randomized trials in cognitively impaired/dementia populations showing (or failing to show) that targeted management of autonomic dysfunction, medication reduction, and cognitive–motor combined training reduces falls would either strengthen or falsify the review's practical recommendations.
• Objective ambulatory monitoring (wearables, remote digital biomarkers) validating fall events and their precursors in dementia cohorts would reduce recall bias and clarify causal chains. (See recent digital biomarker work highlighting feasibility of remote cognitive/behavioral monitoring.) Digital biomarkers for cognition & falls

Recommendations for researchers and clinicians (concise)

1. Prioritize prospective, dementia-specific RCTs of multifactorial interventions with objective fall ascertainment (wearables, monthly calendars) and subgroup analyses by dementia subtype (AD, VaD, DLB).
2. Systematically measure autonomic function (orthostatic BP, tilt tests, carotid sinus testing) in dementia fall cohorts to quantify attributable risk and treatment targets.
3. Audit and reduce psychotropic/anticholinergic burden where possible and evaluate fall outcomes after deprescribing in dementia cohorts (randomized or rigorous quasi-experimental designs).
4. Use combined cognitive–motor rehabilitation (dual-task training) and test transfer to real-world fall rates in dementia subgroups; ensure feasibility/adherence is measured and reported.